Netherlocks partial stroke system meets SIL 3

Published: 29-Apr-2010
Manufacturing

According to FMEDA report by Exida, the Netherlocks partial stoke system FAITH (Fail Action Integrity Test Handling) is very reliable

The FMEDA report showed the Netherlocks partial stoke system FAITH (Fail Action Integrity Test Handling) to be very reliable, with 0 Fail Safe Detected, Fail Safe Undetected and Fail Dangerous Detected conditions recorded from the tests. For most cases, the FAITH is suitable for use in SIL3 applications.

The FAITH system makes it possible to carry out a manually initiated partial stroke test on ESD (Emergency Shut Down) valves during normal operation, without interrupting process flow. It limits, with mechanical stops, the angle of the stroke of the valve-actuator combination to a set percentage – ensuring the ESD valve ‘works’, without actually shutting down the operation. By operating mechanically rather than relying on electronic contacts or signals, reliability and simplicity is maximised.

An FMEDA (Failure Modes, Effects, and Diagnostic Analysis) assessment has been carried out by Exida on Netherlocks’ FAITH system. The product was subject to a thorough examination according to IEC 61508 to determine Probability of Failure on Demand (PFD) statistics for this device. The failure rates of the FAITH System must be added to the failure rates of the valve-actuator combination when determining the PFD AVG and Safe Failure Fraction (SFF) for the final element.

More details, a summary and the report itself are available to customers upon request from sales@netherlocks.com or at www.netherlocks.com.
See more

You may also like

Manufacturing

Two leading valve operation brands merge to form Sofis

Read more
Netherlocks and Smith Flow Control reveal new corporate identity

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  2. Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
  3. Simplifying continuous operations: lowering the barrier to faster development Continuous manufacturing has long promised faster development, improved process understanding and, in the absence of scale-up, smoother commercialization. For many pharmaceutical R&D teams, those benefits are well understood. What still holds them back, however, is not scepticism about the concept; it’s the perceived effort required to implement it
  4. Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle
  5. Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Two leading valve operation brands merge to form Sofis

Netherlocks and Smith Flow Control reveal new corporate identity
Manufacturing

Almac highlights SDS-PAGE approach for residual protein determination in new white paper

New white paper explores robust analytical method for residual protein detection in biocatalytic API manufacturing
Manufacturing

Reliable, high-performance pump for HPLC and UHPLC

Biotech Fluidics announce the ASI 540 – an affordable, standalone solvent delivery pump - design optimised for liquid chromatography applications
Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing

Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform

The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing

Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Subscribe now